• HOME
  • ABOUT
    • VISION SCIENCE RESEARCH
  • DRC
    • Department of Research Collaboration
  • DTC
    • Department of Technology Commercialization
  • RESEARCHERS
    • Our Co-Researchers
  • CONTACT
First slide
First slide
First slide
Research Collaboration / Projects Under Study/Medicine

Contact us

Email*
First name*
Surname
Country*
I am representing*
Enquiry Subject*
0/100
Your enquiry*
0/1900
Projects Under Study
Computer Science Engineering Medicine Social Science Environmental Science Education Agriculture
Last update:22 Apr 2022

Reagent for Monitoring Cancer Therapy Resistance in Real-Time and Extensive Cancer Screening (Tumor Signal-Liquid Biopsy)

Therapy resistances in cancer are often undetectable or detected too late by current methods (CT scan & liquid biopsy), cause patient death and huge expenses in the medical and economic systems! The tumor signal transduction oncoproteins insides tumor cells control tumor survival. With the world‘s first invention “Tumor Signal-Liquid Biopsy” (to assay the tumor signal transduction activity in blood from cancer patients), our product (DxSure) monitors the therapy resistances of all cancer types and all therapy methods in real-time. Our product can help cancer patients get correct drug in time.
  • HOME|
  • ABOUT|
  • DRC |
  • DTC|
  • RESEARCHERS|
  • CONTACT
Vision Science Research © 2016 All Rights Reserved Terms of Use and Privacy Policy

VISION SCIENCE RESEARCH SDN BHD, which is short for VSR, is a mature international academic exchange platform jointly established by worldwide universities, research institutes and enterprises in Malaysia.